EBRD Supports Morocco’s Pharmaceutical Sector with €34.5 Mln Loan

The facility to Dislog will consist of two tranches. €24.5 million will be used to acquire Steripharma, a local pharmaceuticals manufacturer that provides affordable specialty generics medicines to replace expensive original products in the treatment of life-threatening diseases, a press release from the EBRD says.

The remaining €10 million loan will finance the construction of a new green-certified industrial building and logistics platform as well as the installation of photovoltaic (PV) panels, the Bank adds.

The new PV panels are expected to generate energy to power the building and will help reduce CO2 emissions. This tranche will be supported by a guarantee from the European Union (EU) through its European Fund for Sustainable Development (EFSD), in line with the objective of the EU-Morocco Green Partnership.

The investment will enable Dislog to expand into the pharmaceuticals industry and capture higher added value in the supply chains in Morocco. The acquisition of Steripharma will complement Dislog’s established competence in reaching a wide network of small distribution outlets and help increase profit from its existing distribution channels and logistics chains.

The loan will be accompanied by a technical assistance project funded by the EU through the EFSD programme to upgrade its human resources policies by implementing a dedicated Gender Diagnostic and Action Plan, according to the same source.

Dislog will also receive a grant from the FINTECC Programme, which helps companies in participating EBRD economies to implement innovative climate technologies. The programme is part of, and financed through, the EBRD’s Green Economy Transition approach and is supported by the Global Environment Facility and the European Union.

Dislog is a leading distributor of fast-moving consumer goods covering more than 70.000 retailers across the country. Founded in 2005, the company has diversified its activities into industrial production in agribusiness products, hygiene and pharmaceuticals.

Morocco is a founding member of the EBRD and became a beneficiary of Bank resources in 2012. To date the EBRD has invested €4.2 billion in the country through 95 projects.

The European Bank for Reconstruction and Development (EBRD) is supporting Morocco's private pharmaceutical sector with a €34.5 million loan to Dislog Group, a leading manufacturer and distributor of various consumer goods.

25 September 2023